Stock Earnings
NTLA’s latest rating updates from top analysts.
In a filing, Intellia Therapeutics Inc revealed its EVP, Chief Scientific Officer Schultes Birgit C unloaded Company’s shares for reported
Menu
In a filing, Intellia Therapeutics Inc revealed its EVP, Chief Scientific Officer Schultes Birgit C unloaded Company’s shares for reported
Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its
In a filing, Intellia Therapeutics Inc revealed its Director CHASE WILLIAM J acquired Company’s shares for reported $1.0 million on
Intellia Therapeutics Inc’s recent filing unveils that its Director CHASE WILLIAM J acquired Company’s shares for reported $1.0 million on
Intellia Therapeutics Inc’s recent filing unveils that its Director CHASE WILLIAM J acquired Company’s shares for reported $1.0 million on
Intellia Therapeutics Inc’s recently made public that its Director CHASE WILLIAM J acquired Company’s shares for reported $1.0 million on
Intellia Therapeutics Inc’s recently made public that its Director CHASE WILLIAM J acquired Company’s shares for reported $1.0 million on
In a filing, Intellia Therapeutics Inc revealed its EVP, Chief Financial Officer Dulac Edward J III unloaded Company’s shares for